Telmisartan-induced PPARγ activity attenuates lipid accumulation in VSMCs via induction of autophagy. (Q50459687)

14 March 2018

title

Telmisartan-induced PPARγ activity attenuates lipid accumulation in VSMCs via induction of autophagy. (English)

1 reference

14 March 2018

1 reference

Bing-Hu Li

1

1 reference

14 March 2018

Shao-Qiong Liao

2

1 reference

14 March 2018

Yan-Wei Yin

3

1 reference

14 March 2018

Chun-Yan Long

4

1 reference

14 March 2018

Lu Guo

5

1 reference

14 March 2018

Xiao-Jie Cao

6

1 reference

14 March 2018

Yun Liu

7

1 reference

14 March 2018

Yi Zhou

8

1 reference

14 March 2018

Chang-Yue Gao

9

1 reference

14 March 2018

Li-Li Zhang

10

1 reference

14 March 2018

Jing-Cheng Li

11

1 reference

14 March 2018

publication date

24 September 2014

1 reference

14 March 2018

Molecular Biology Reports

published in

1 reference

14 March 2018

volume

42

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

page(s)

179-186

1 reference

14 March 2018

https://scigraph.springernature.com/pub.10.1007/s11033-014-3757-6

exact match

0 references

cites work

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Peroxisome proliferator-activated receptor-γ agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

p38 mitogen-activated protein kinase (MAPK) promotes cholesterol ester accumulation in macrophages through inhibition of macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

TRPV1 activation impedes foam cell formation by inducing autophagy in oxLDL-treated vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

AMPK and mTOR coordinate the regulation of Ulk1 and mammalian autophagy initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Autophagy in the Pathogenesis of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Macrophage autophagy plays a protective role in advanced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Atorvastatin protects vascular smooth muscle cells from TGF-β1-stimulated calcification by inducing autophagy via suppression of the β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

AMP-activated Protein Kinase and the Regulation of Autophagic Proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Acetylcholine mediates AMPK-dependent autophagic cytoprotection in H9c2 cells during hypoxia/reoxygenation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

The role of the Atg1/ULK1 complex in autophagy regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

The coordinate regulation of the p53 and mTOR pathways in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3757-6

Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25249228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25249228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of telmisartan on inflammatory cytokines and coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25249228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11033-014-3757-6

1 reference

14 March 2018

PubMed ID

25249228

1 reference

14 March 2018